JP2008515999A5 - - Google Patents

Download PDF

Info

Publication number
JP2008515999A5
JP2008515999A5 JP2007536964A JP2007536964A JP2008515999A5 JP 2008515999 A5 JP2008515999 A5 JP 2008515999A5 JP 2007536964 A JP2007536964 A JP 2007536964A JP 2007536964 A JP2007536964 A JP 2007536964A JP 2008515999 A5 JP2008515999 A5 JP 2008515999A5
Authority
JP
Japan
Prior art keywords
composition
disease
amd
crig
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007536964A
Other languages
English (en)
Japanese (ja)
Other versions
JP4897690B2 (ja
JP2008515999A (ja
Filing date
Publication date
Priority claimed from US10/964,263 external-priority patent/US7419663B2/en
Priority claimed from US11/159,919 external-priority patent/US8088386B2/en
Application filed filed Critical
Publication of JP2008515999A publication Critical patent/JP2008515999A/ja
Publication of JP2008515999A5 publication Critical patent/JP2008515999A5/ja
Application granted granted Critical
Publication of JP4897690B2 publication Critical patent/JP4897690B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007536964A 2004-10-12 2005-10-12 補体関連障害の予防および処置のためのＣＲＩｇポリペプチド Expired - Fee Related JP4897690B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10/964,263 US7419663B2 (en) 1998-03-20 2004-10-12 Treatment of complement-associated disorders
US10/964,263 2004-10-12
US11/159,919 2005-06-22
US11/159,919 US8088386B2 (en) 1998-03-20 2005-06-22 Treatment of complement-associated disorders
PCT/US2005/037114 WO2006042329A2 (en) 2004-10-12 2005-10-12 Crig polypeptide for prevention and treatment of complement-associated disorders

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011197573A Division JP2011246495A (ja) 2004-10-12 2011-09-09 補体関連障害の予防および処置のためのＣＲＩｇポリペプチド

Publications (3)

Publication Number Publication Date
JP2008515999A JP2008515999A (ja) 2008-05-15
JP2008515999A5 true JP2008515999A5 (https=) 2008-11-13
JP4897690B2 JP4897690B2 (ja) 2012-03-14

Family

ID=45418822

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007536964A Expired - Fee Related JP4897690B2 (ja) 2004-10-12 2005-10-12 補体関連障害の予防および処置のためのＣＲＩｇポリペプチド
JP2011197573A Withdrawn JP2011246495A (ja) 2004-10-12 2011-09-09 補体関連障害の予防および処置のためのＣＲＩｇポリペプチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011197573A Withdrawn JP2011246495A (ja) 2004-10-12 2011-09-09 補体関連障害の予防および処置のためのＣＲＩｇポリペプチド

Country Status (1)

Country Link
JP (2) JP4897690B2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013255050B2 (en) * 2012-05-01 2016-07-28 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
US9657103B2 (en) * 2012-05-02 2017-05-23 New York University Methods of treating and preventing Staphylococcus aureus infections and associated conditions
WO2022010273A1 (ko) * 2020-07-07 2022-01-13 주식회사 카나프테라퓨틱스 보체 경로 억제제를 포함하는 융합단백질 및 이의 용도
CN112364512B (zh) * 2020-11-13 2024-03-08 华东理工大学 基于鲍威尔搜索算法的乙烯裂解炉负荷优化方法
KR20230105972A (ko) 2022-01-05 2023-07-12 주식회사 카나프테라퓨틱스 혈관신생 억제제가 결합된 항-C3b 항체 또는 항-C5 항체 및 이의 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9301289D0 (en) * 1993-01-22 1993-03-17 Smithkline Beecham Plc Novel composition
ATE410512T1 (de) * 1997-11-21 2008-10-15 Genentech Inc Plättchen-spezifische antigene und deren pharmazeutische verwendung
US7192589B2 (en) * 1998-09-16 2007-03-20 Genentech, Inc. Treatment of inflammatory disorders with STIgMA immunoadhesins
CA2362427A1 (en) * 1999-03-08 2000-09-14 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
EP1234030A4 (en) * 1999-11-19 2003-05-07 Human Genome Sciences Inc 18 HUMANE SECRETIED PROTEINS
AU2003258714A1 (en) * 2002-09-06 2004-03-29 Cytos Biotechnology Ag Immune modulatory compounds and methods
US20060251621A1 (en) * 2002-09-27 2006-11-09 Campochiaro Peter A Ocular gene therapy

Similar Documents

Publication Publication Date Title
JP2011519950A5 (https=)
JP2011504872A5 (https=)
RU2009149385A (ru) АНТИТЕЛА ПРОТИВ С3b И СПОСОБЫ ПРОФИЛАКТИКИ И ЛЕЧЕНИЯ СВЯЗАННЫХ С КОМПЛЕМЕНТОМ НАРУШЕНИЙ
HRP20161580T1 (hr) CRIg-VARIJANTE S RAZVIJENIM AFINITETOM
JP2016222702A5 (https=)
FI3215527T3 (fi) Humanisoituja anti-komplementtitekijä c1q -vasta-aineita ja niiden käyttöjä
JP2014516945A5 (https=)
RU2019102393A (ru) Гуманизированные антитела к фактору d и их применения
JP2022507741A5 (https=)
JP2007514419A5 (https=)
US10858420B2 (en) Methods of treating hemolytic disorders comprising administering an anti-C3b antibody
JP2018511609A5 (https=)
RU2011110169A (ru) Антитела против ccr2
JP2015526064A5 (https=)
JP2019503167A5 (https=)
JP2008515999A5 (https=)
CN103396494B (zh) 一种凝血因子ix的单克隆抗体
FI4268843T3 (fi) Parannettuja il-6-vasta-aineita
JP2019503706A5 (https=)
RU2013153902A (ru) Аналоги фактора комплемента в и их применения
US20060188505A1 (en) Treatment of autism
JP2019520405A5 (https=)
JP2011518857A5 (https=)
JP2011520959A5 (https=)
JP2018502112A5 (https=)